CIK 0001944552 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-10-15 |
| 2026-10-01 | 4 | PRIMARY DOCUMENT | 2026-09-29 |
| 2026-09-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-09-30 |
| 2026-09-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-09-30 |
| 2026-09-24 | 4 | PRIMARY DOCUMENT | 2026-09-22 |
| 2026-09-18 | 144 | 144 | |
| 2026-09-15 | EFFECT | EFFECT items ,, | |
| 2026-09-11 | S-8 POS | REGISTRATION STATEMENT | |
| 2026-09-11 | S-8 POS | REGISTRATION STATEMENT | |
| 2026-09-11 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | |
| 2026-09-08 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-09-08 |
| 2026-08-26 | 4 | PRIMARY DOCUMENT | 2026-08-24 |
| 2026-08-26 | 6-K | CURRENT REPORT | 2026-08-26 |
| 2026-08-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-19 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-14 |
| 2026-08-04 | 3 | PRIMARY DOCUMENT | 2026-03-18 |
| 2026-08-03 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-03 |
| 2026-07-20 | 424B7 | PROSPECTUS SUPPLEMENT | |
| 2026-07-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-16 |
| 2026-07-15 | 3 | 3 | 2026-03-18 |
| 2026-06-10 | 4 | PRIMARY DOCUMENT | 2018-12-16 |
| 2026-06-01 | 3 | PRIMARY DOCUMENT | 2026-05-28 |
| 2026-05-28 | 3 | PRIMARY DOCUMENT | 2026-03-18 |
Forms on file (last 1,000): 6-K 26, CORRESP 10, UPLOAD 10, 3 8, SC 13G 6, 4 5, SCHEDULE 13G 5, DRSLTR 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ANL (0.002 USD), /gw/filings/filings?ticker=ANL&form=8-K, /gw/filings/facts?ticker=ANL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange